Volume 5, 2 Issues, 2018 ISSN: 2212-7089 (Online) ISSN: 2212-7070 (Print)
This journal supports open access
Aims & Scope
Clinical Immunology, Endocrine & Metabolic Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical immunology, endocrine & metabolic drug research.
The journal publishes pre-clinical and clinical studies on the development of new immunology, endocrine & metabolic agents. Clinical studies of new reported immunology, endocrine & metabolic drugs include Phase 1 - IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinicians, toxicologists, medicinal chemists, and pharmacologists.
Mariagrazia Roselli, Angelo Lovece, Claudio Bruno, Maria M. Cavalluzzi, Antonio Laghezza, Annalisa Mercurio, Giovanni Lentini, Filomena Corbo, Flavia la Forgia, Sergio Fontana, Solomon Habtemariam and Carlo Franchini